BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33320757)

  • 21. Fibrous dysplasia & McCune-Albright syndrome: an experience from a tertiary care centre in north India.
    Bhadada SK; Bhansali A; Das S; Singh R; Sen R; Agarwal A; Mittal BR; Nahar U; Dutta P; Khandelwal N
    Indian J Med Res; 2011 May; 133(5):504-9. PubMed ID: 21623035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and molecular aspects of McCune-Albright syndrome.
    Lietman SA; Schwindinger WF; Levine MA
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():380-5. PubMed ID: 17982384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral pigmentation in McCune-Albright syndrome.
    Pichard DC; Boyce AM; Collins MT; Cowen EW
    JAMA Dermatol; 2014 Jul; 150(7):760-3. PubMed ID: 24671640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome.
    Shenker A; Weinstein LS; Sweet DE; Spiegel AM
    J Clin Endocrinol Metab; 1994 Sep; 79(3):750-5. PubMed ID: 8077356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Odontoiatric perspectives and osteonecrosis of the jaw as a possible adverse effect of bisphosphonates therapy in fibrous dysplasia and McCune-Albright syndrome.
    Tessaris D; Matarazzo P; Lala R; Defabianis P
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):333-6. PubMed ID: 26565547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical approach to clarifying the mechanism of abnormal bone metabolism in McCune-Albright syndrome.
    Yamamoto T
    J Bone Miner Metab; 2006; 24(1):7-10. PubMed ID: 16369891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.
    Salpea P; Stratakis CA
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):85-91. PubMed ID: 24012779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unusual phenotypical variations in a boy with McCune-Albright syndrome.
    Mamkin I; Philibert P; Anhalt H; Ten S; Sultan C
    Horm Res Paediatr; 2010; 73(3):215-22. PubMed ID: 20197676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Clinical Spectrum of McCune-Albright Syndrome and Its Management.
    Spencer T; Pan KS; Collins MT; Boyce AM
    Horm Res Paediatr; 2019; 92(6):347-356. PubMed ID: 31865341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrous dysplasia of bone and McCune-Albright syndrome.
    Chapurlat RD; Orcel P
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. McCune-Albright syndrome and type 1 diabetes mellitus: a novel presentation.
    Chatty P; Khattab A; Marshall I
    Ann N Y Acad Sci; 2020 Mar; 1463(1):5-8. PubMed ID: 32037600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
    Robinson C; Collins MT; Boyce AM
    Curr Osteoporos Rep; 2016 Oct; 14(5):178-86. PubMed ID: 27492469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy.
    Ringel MD; Schwindinger WF; Levine MA
    Medicine (Baltimore); 1996 Jul; 75(4):171-84. PubMed ID: 8699958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining Real-Time COLD- and MAMA-PCR TaqMan Techniques to Detect and Quantify R201 GNAS Mutations in the McCune-Albright Syndrome
.
    de Sanctis L; Galliano I; Montanari P; Matarazzo P; Tessaris D; Bergallo M
    Horm Res Paediatr; 2017; 87(5):342-349. PubMed ID: 28334704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal McCune-Albright syndrome with survival beyond two years.
    Pierce M; Scottoline B
    Am J Med Genet A; 2016 Nov; 170(11):3008-3012. PubMed ID: 27411099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
    Lietman SA; Ding C; Levine MA
    J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difficulties in diagnosis and treatment of acromegaly in a patient with a McCune-Albright syndrome. A case report and a review of literature.
    Baszko-Błaszyk D; Slynko J; Liebert W; Sosnowski P; Sowiński J; Waśko R
    Neuro Endocrinol Lett; 2010; 31(5):594-6. PubMed ID: 21173751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
    Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome.
    Weinstein LS
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P120-4. PubMed ID: 17229000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis.
    Parvanescu A; Cros J; Ronot M; Hentic O; Grybek V; Couvelard A; Levy P; Chanson P; Ruszniewski P; Sauvanet A; Gaujoux S
    JAMA Surg; 2014 Aug; 149(8):858-62. PubMed ID: 24898823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.